Exane Derivatives’s Willis Towers Watson WTW Stock Holding History

Exane Derivatives’s Portfolio WTW Stock Details WTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-188	Closed	-$43.7K	–	1072
2021 Q3	$43.7K	Buy	+188	New	+$41.8K	0.01%	631
2019 Q2	–	Sell	-1,189	Closed	-$209K	–	730
2019 Q1	$209K	Sell	1,189 -148	-11%	-$24.6K	0.04%	216
2018 Q4	$203K	Hold	1,337	–	–	0.04%	243
2018 Q3	$189K	Sell	1,337 -63	-5%	-$9.53K	0.04%	254
2018 Q2	$214K	Buy	+1,400	New	+$213K	0.04%	258

Other funds holding WTW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Exane Derivatives's WTW Position: Q4 2021 in Review

Exane Derivatives sold out of Willis Towers Watson (WTW) in Q4 2021, closing a stake of 188 shares — an estimated $43.7K sold.

Exane Derivatives first reported a position in WTW in Q2 2018 and held it in 5 quarters. The position peaked at $214K in Q2 2018. 580 funds tracked by Wall St. Rank hold WTW as of Q4 2021.

Exane Derivatives reported no remaining Willis Towers Watson position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 188 Willis Towers Watson shares in Q4 2021, an estimated $43.7K.
Exane Derivatives first reported a position in Willis Towers Watson in Q2 2018 and held it in 5 quarters.
Exane Derivatives's Willis Towers Watson position peaked at $214K in Q2 2018.
580 funds tracked by Wall St. Rank held Willis Towers Watson as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.